United States Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals' Solid Oral Oncology facility located at Panelav from June 24, 2019 to June 28, 2019. This was a first scheduled inspection and company passed the inspection without any Form 483 Observation.
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.